Striking out is painful, but is not as impactful as missing out on the next potential home run because you're still brooding about whiffing on your last investment.
Parabolic moves can be alluring, but if you are long on SLP, consider how far it can fall from here.
Citron analyst sees 'indestructible moat' around genetic-testing company's business.
Another day, another busy earnings day! What to watch on Wednesday, July 31, 2019.
The merger with Pfizer's off-patent branded medicines business may be a life-preserver for bulls and provide meaningful expansion across geographical regions while leveraging Pfizer's commercialization capabilities.
Let's check out the latest charts and indicators.
Jounce Therapeutics and Ocular Therapeutix each provided investors with positive news morsels last week.
Jim Cramer tackles Starbucks, the Federal Reserve, earnings and Mylan ahead of a week filled with potentially market-moving headlines.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.